blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2381948

EP2381948 - Compounds for enhancing erythropoiesis [Right-click to bookmark this link]
Former [2011/44]COMPOUNDS AND METHODS FOR ENHANCING ERYTHROPOIESIS
[2014/40]
StatusNo opposition filed within time limit
Status updated on  29.01.2016
Database last updated on 13.07.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Wu, Sophia Shu Fen
426 Park Avenue
Yonkers, NY 10703 / US
For all designated states
Wu, Rong-Tsun
No. 155, Sec. 2 Linong Street
Taipei 112 / TW
[2015/13]
Former [2011/44]For all designated states
Wu, Sophia Shu Fen
426 Park Avenue
Yonkers, NY 10703 / US
For all designated states
Wu, Rong-Tsun
No. 155, Sec. 2 Linong Street
Taipei 112 / TW
Inventor(s)01 / WU, Rong-Tsun
No. 155, Sec. 2
Linong Street
Taipei 112 / TW
 [2011/44]
Representative(s)Becker Kurig & Partner Patentanwälte mbB
Bavariastraße 7
80336 München / DE
[N/P]
Former [2015/13]Becker Kurig Straus
Patentanwälte
Bavariastrasse 7
80336 München / DE
Former [2014/33]Becker Kurig Straus
Bavariastrasse 7
80336 München / DE
Former [2011/44]Epping - Hermann - Fischer
Patentanwaltsgesellschaft mbH Ridlerstraße 55
80339 München / DE
Application number, filing date09775516.921.12.2009
WO2009US68957
Priority number, dateUS2008034392224.12.2008         Original published format: US 343922
[2011/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010075263
Date:01.07.2010
Language:EN
[2010/26]
Type: A2 Application without search report 
No.:EP2381948
Date:02.11.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 01.07.2010 takes the place of the publication of the European patent application.
[2011/44]
Type: B1 Patent specification 
No.:EP2381948
Date:25.03.2015
Language:EN
[2015/13]
Search report(s)International search report - published on:EP19.08.2010
ClassificationIPC:A61K31/7034, A61P7/06, A61P13/12, A61P25/00, A61P9/00, A61P9/10, A61P1/16, A61P11/00, A61P1/00, A61P19/08, A61P19/02, A61P21/00, A61P17/00, A61P43/00, A61P37/08
[2011/44]
CPC:
A61K31/7034 (EP,KR,US); A61P1/00 (EP); A61P1/04 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P13/12 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P19/00 (EP);
A61P19/02 (EP); A61P19/08 (EP); A61P21/00 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/28 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P7/00 (EP); A61P7/06 (EP);
A61P9/00 (EP); A61P9/10 (EP); A61P9/14 (EP);
C07H15/203 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/13]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:Verbindungen zur Verstärkung der Erythropoese[2014/40]
English:Compounds for enhancing erythropoiesis[2014/40]
French:Composés pour l'amplification de l'érythropoïèse[2014/40]
Former [2011/44]VERBINDUNGEN UND VERFAHREN ZUR VERSTÄRKUNG DER ERYTHROPOESE
Former [2011/44]COMPOUNDS AND METHODS FOR ENHANCING ERYTHROPOIESIS
Former [2011/44]COMPOSÉS ET MÉTHODE D'AMPLIFICATION DE L'ÉRYTHROPOÏÈSE
Entry into regional phase20.07.2011National basic fee paid 
20.07.2011Designation fee(s) paid 
20.07.2011Examination fee paid 
Examination procedure20.07.2011Examination requested  [2011/44]
30.03.2012Amendment by applicant (claims and/or description)
09.07.2012Despatch of a communication from the examining division (Time limit: M04)
07.11.2012Reply to a communication from the examining division
14.01.2013Despatch of a communication from the examining division (Time limit: M04)
14.05.2013Reply to a communication from the examining division
11.07.2013Despatch of a communication from the examining division (Time limit: M04)
14.11.2013Reply to a communication from the examining division
07.02.2014Despatch of a communication from the examining division (Time limit: M04)
02.06.2014Reply to a communication from the examining division
11.09.2014Communication of intention to grant the patent
09.01.2015Fee for grant paid
09.01.2015Fee for publishing/printing paid
09.01.2015Receipt of the translation of the claim(s)
Divisional application(s)EP14176172.6  / EP2893930
EP19206081.2  / EP3628321
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.07.2012
Opposition(s)05.01.2016No opposition filed within time limit [2016/09]
Fees paidRenewal fee
23.12.2011Renewal fee patent year 03
21.12.2012Renewal fee patent year 04
20.12.2013Renewal fee patent year 05
30.09.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.12.2009
AT25.03.2015
BE25.03.2015
BG25.03.2015
CY25.03.2015
CZ25.03.2015
DK25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
IT25.03.2015
LT25.03.2015
LV25.03.2015
MC25.03.2015
MK25.03.2015
MT25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SI25.03.2015
SK25.03.2015
SM25.03.2015
TR25.03.2015
NO25.06.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
IE21.12.2015
LU21.12.2015
[2018/30]
Former [2017/38]HU21.12.2009
AT25.03.2015
BE25.03.2015
BG25.03.2015
CY25.03.2015
CZ25.03.2015
DK25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
IT25.03.2015
LT25.03.2015
LV25.03.2015
MC25.03.2015
MT25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SI25.03.2015
SK25.03.2015
SM25.03.2015
TR25.03.2015
NO25.06.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
IE21.12.2015
LU21.12.2015
Former [2016/45]AT25.03.2015
BE25.03.2015
CZ25.03.2015
DK25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
IT25.03.2015
LT25.03.2015
LV25.03.2015
MC25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SI25.03.2015
SK25.03.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
IE21.12.2015
LU21.12.2015
Former [2016/36]AT25.03.2015
BE25.03.2015
CZ25.03.2015
DK25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
IT25.03.2015
LT25.03.2015
LV25.03.2015
MC25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SI25.03.2015
SK25.03.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
LU21.12.2015
Former [2016/34]AT25.03.2015
CZ25.03.2015
DK25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
IT25.03.2015
LT25.03.2015
LV25.03.2015
MC25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SI25.03.2015
SK25.03.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
LU21.12.2015
BE31.12.2015
Former [2016/33]AT25.03.2015
CZ25.03.2015
DK25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
IT25.03.2015
LT25.03.2015
LV25.03.2015
MC25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SI25.03.2015
SK25.03.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
BE31.12.2015
Former [2016/24]AT25.03.2015
CZ25.03.2015
DK25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
IT25.03.2015
LT25.03.2015
LV25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SI25.03.2015
SK25.03.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
BE31.12.2015
Former [2016/21]AT25.03.2015
CZ25.03.2015
DK25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
IT25.03.2015
LT25.03.2015
LV25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SK25.03.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
Former [2016/07]AT25.03.2015
CZ25.03.2015
DK25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
LT25.03.2015
LV25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SK25.03.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
Former [2015/51]AT25.03.2015
CZ25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
LT25.03.2015
LV25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SK25.03.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
Former [2015/50]CZ25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
LT25.03.2015
LV25.03.2015
NL25.03.2015
PL25.03.2015
RO25.03.2015
SE25.03.2015
SK25.03.2015
GR26.06.2015
IS25.07.2015
PT27.07.2015
Former [2015/49]CZ25.03.2015
EE25.03.2015
ES25.03.2015
FI25.03.2015
HR25.03.2015
LT25.03.2015
LV25.03.2015
NL25.03.2015
RO25.03.2015
SE25.03.2015
SK25.03.2015
GR26.06.2015
PT27.07.2015
Former [2015/41]FI25.03.2015
HR25.03.2015
LT25.03.2015
LV25.03.2015
NL25.03.2015
SE25.03.2015
GR26.06.2015
Former [2015/39]FI25.03.2015
HR25.03.2015
LT25.03.2015
LV25.03.2015
SE25.03.2015
GR26.06.2015
Former [2015/37]FI25.03.2015
HR25.03.2015
LT25.03.2015
SE25.03.2015
GR26.06.2015
Former [2015/36]FI25.03.2015
HR25.03.2015
LT25.03.2015
SE25.03.2015
Former [2015/35]LT25.03.2015
Cited inInternational search[A]CN1303858  ;
 [XD]US2005042314  (WU RONG-TSUN [TW]) [XD] 1-6,9,10 * claims 1, 8-9 * * example 10 * * paragraph [0017] *;
 [A]  - ZHANG WEI ET AL, "Treatment with 2,3,4',5-tetrahydroxystilbene-2-O-.beta.-D-glucoside in atherosclerosis in rats", ZHONGGUO YAOKE DAXUE XUEBAO - JOURNAL OF CHINA PHARMACEUTICAL UNIVERSITY, NANJING, CN, (20070101), vol. 38, no. 3, ISSN 1000-5048, pages 261 - 264, XP008119057 [A] 1-6,9,10 * abstract *
 [A]  - JIA XIN ET AL, "Neuroprotective effect of tetrahydroxystilbene glucoside on the rat model of Parkinson 's disease", ZHONGGUO XIN YAO ZAZHI - CHINESE NEW DRUGS JOURNAL, GAI-KAN BIANJIBU, BEIJING, CN, (20080101), vol. 17, no. 9, ISSN 1003-3734, pages 748 - 752, XP008119058 [A] 1-6,9,10 * abstract *
 [A]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2001, no. 63, Database accession no. 2001-558353, XP002569662 & CN1303858 A 20010718 (NO 2 MILITARY MEDICAL COLLEGE PLA) [A] 1-6,9,10 * abstract *
 [AD]  - WANG ET AL, "Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-gluco side, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER BV, NL, (20071025), vol. 578, no. 2-3, ISSN 0014-2999, pages 339 - 348, XP022405039 [AD] 1-6,9,10 * abstract * * page 340, column l, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/j.ejphar.2007.09.013
 [A]  - KIMURA Y ET AL, "EFFECTS OF NATURALLY OCCURRING STILBENE GLUCOSIDES FROM MEDICINAL PLANTS AND WINE, ON TUNOUR GROWTH AND LUNG METASTASIS IN LEWIS LUNG CARCINOMA-BEARING MICE", JOURNAL OF PHARMACY AND PHARMACOLOGY, ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN, GB, (20001001), vol. 10, no. 52, ISSN 0022-3573, pages 1287 - 1295, XP001069866 [A] 1-6,9,10 * abstract *

DOI:   http://dx.doi.org/10.1211/0022357001777270
Examination   - S. Nurko, "Anemia in chronic kidney disease: causes, diagnosis, treatment.", Cleveland Clinic Journal of Medicine, (20060301), vol. 73, no. 3, doi:10.3949/ccjm.73.3.289, ISSN 0891-1150, pages 289 - 297, XP055099863

DOI:   http://dx.doi.org/10.3949/ccjm.73.3.289
    - T Stopka ET AL, "Human Hematopoietic Progenitors Express Erythropoietin", Blood, UNITED STATES, (19980515), pages 3766 - 3772, URL: http://www.ncbi.nlm.nih.gov/pubmed/9573013, (20140821), XP055135874
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.